[Clinical experience with bencyclane in internal medicine].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001772:Blood Cell Count; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003508:Cycloheptanes / Q000009:adverse effects / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004231:Diuresis / Q000187:drug effects; D004617:Embolism / Q000188:drug therapy; D005260:Female; D005650:Fumarates / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011437:Propylamines / Q000009:adverse effects / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013035:Spasm / Q000188:drug therapy; D013919:Thromboangiitis Obliterans / Q000188:drug therapy; D014456:Ulcer / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy; D014717:Vertigo / Q000139:chemically induced
D003508:Cycloheptanes; D005650:Fumarates; D010276:Parasympatholytics; D011437:Propylamines
Klinische Erfahrungen mit Bencyclan in der inneren Medizin.